$95M mega-round in hand, Elaine Sullivan sets out to build a European oncology player
A trans-Atlantic investment syndicate that includes Google has come together to bankroll a European oncology startup with a $95 million mega-round. And the biotech, helmed by experienced pharma R&D exec Elaine Sullivan, has already lined up three development programs with plans to add more in the very near future.
The big idea here has less to do with any one program and scientific founder than it has to do with the continental-sized partnering aspirations at Carrick Therapeutics.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.